Literature DB >> 9468057

Effect of Tissucol on connective tissue matrix during wound healing: an immunohistochemical study in rat skin.

G E Romanos1, J R Strub.   

Abstract

Fibrin sealants are very useful in different surgical fields. Fixation of free gingival grafts, root coverage procedures, and other techniques increasing connective tissue attachment may be associated with the application of Tissucol in periodontology. The aim of this study was to evaluate the influence of the fibrin sealant in the extracellular matrix, as well as alterations of the connective tissue matrix during wound-healing processes. In the back dermis of 15 Net male rats, Tissucol was implanted after intraperitoneal anesthesia. The implant material was placed in subcutaneous pockets (2 cm in length) which were sutured with interproximal sutures (test and control pockets). At 4, 7, 14, 21, and 28 days after surgery, biopsies of the healed and surrounding tissues were taken, frozen in liquid nitrogen, and examined histologically and immunohistochemically with antibodies against collagen types I, III, IV, V, VI, and VII. The findings showed thick and thin collagen type I and III fibers, respectively, with different orientations localized around the implant material. An increased amount of blood vessels and capillaries (their basement membranes containing collagen type IV) was observed during wound healing which may be associated with the implantation of the sealant. Collagen type V fibers were localized from the first days to the 4th postoperative week and, without any inflammatory reaction (according to histologic staining), formed a fibrillar extracellular matrix with high collagenase resistance. Collagen type VI showed a microfibrillar pattern of distribution, and collagen type VII was localized in the dermo epidermo junction and very deep in the connective tissue in the form of anchoring fibers (only in the test group) during the 4 postoperative weeks of healing. The data showed that Tissucol is a biocompatible component which cannot produce any extensive inflammatory reaction in the matrix. New blood vessel formation, an epithelial-connective tissue interface with high stability, as well as matrix alterations with high resistance in the proteolytic enzymes (i.e., collagenases) can be induced in the connective tissue after use of a fibrin sealant. All of these characteristics may be of great importance in connective tissue healing in periodontal surgical procedures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468057     DOI: 10.1002/(sici)1097-4636(19980305)39:3<462::aid-jbm17>3.0.co;2-c

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  5 in total

1.  Cyanoacrylate glue in the treatment of ano-rectal fistulas.

Authors:  Paolo Barillari; Luigi Basso; Antonella Larcinese; Paolo Gozzo; Marileda Indinnimeo
Journal:  Int J Colorectal Dis       Date:  2006-04-20       Impact factor: 2.571

2.  Gene profiling of the rat medial collateral ligament during early healing using microarray analysis.

Authors:  Connie S Chamberlain; Sabrina H Brounts; David G Sterken; Kevin I Rolnick; Geoffrey S Baer; Ray Vanderby
Journal:  J Appl Physiol (1985)       Date:  2011-05-19

3.  Different angiogenic abilities of self-setting calcium phosphate cement scaffolds consisting of different proportions of fibrin glue.

Authors:  Jintao Xiu; Junjun Fan; Jie Li; Geng Cui; Wei Lei
Journal:  Biomed Res Int       Date:  2014-06-10       Impact factor: 3.411

4.  Fibrin adhesive derived from snake venom in periodontal surgery: histological analysis.

Authors:  Mônica D S Barbosa; Antônio Carlos Stipp; Euloir Passanezi; Sebastião Luis A Greghi
Journal:  J Appl Oral Sci       Date:  2008 Sep-Oct       Impact factor: 2.698

5.  Evaluation of blood vessel ingrowth in fibrin gel subject to type and concentration of growth factors.

Authors:  A Arkudas; J Tjiawi; A Saumweber; J P Beier; E Polykandriotis; O Bleiziffer; R E Horch; U Kneser
Journal:  J Cell Mol Med       Date:  2008-06-28       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.